OTTAWA, Feb. 15, 2018 /Weed Wire/ — As part of its ongoing efforts to provide Canadian pharmacists with practice tools and resources, CPhA has developed a new medical cannabis evidence guide.
Tag Archives: cannabinoids
International Cannabinoid Research Society Heading to Jerusalem in 2021
Cannabis scientists may want to start planning for a trip to the Holy Land. The International Cannabinoid Research Society, the longest running scientific society focused on cannabis research, has picked Jerusalem for the site of its annual International Symposium on the Cannabinoids in 2021.
AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment
NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.
GW Pharmaceuticals Crashed 17% in May
The threat of increasing competition for GW Pharmaceuticals’ promising epilepsy drug took a toll on investors’ confidence last month.
Study: Combination of Cannabinoids and Chemotherapy Kills Leukemia Cells
The combination of cannabinoids and chemotherapy could be the key to improving cancer treatment. This is according to a new study published in the International Journal of Oncology on May 29, 2017.
Wisconsin Files Lawsuits Over Synthetic THC in Milwaukee
On May 23, 2017, two retail shops were sued by Wisconsin’s departments of justice and consumer protection. The Milwaukee stores broke the law as they falsely advertised synthetic THC as household products.
Can This Compound in Marijuana Help Reverse Memory Loss?
Can this prolonged low-dose treatment with a compound in marijuana help reverse memory loss and improve cognitive skills? Researchers say it could.
4 Top Stocks in the Growing Medical Marijuana Industry
Here are 4 top stocks in the growing medical marijuana industry that have a tremendous amount of potential for investors.
West New York Company Grows Marijuana Without the High
A west New York-based biotech company has successfully grown a strain of marijuana that contains zero THC, a feat the company says will transform the medical marijuana industry.
Enter England: Oxford University Launches Medical Cannabis Research Program
Oxford University, one of the oldest and most prestigious universities in the world, recently announced that it is launching a program to research the therapeutic benefits of cannabinoids in the treatment of cancer, inflammatory disease and pain.
Medical Marijuana Inc Fails to Delight Investors
In the last trading session, the stock price of Medical Marijuana Inc (OTCMKTS:MJNA) declined more than 8% to close the day at $0.112. The decline came at a share volume of 24.74 million compared to average share volume of 17.32 million.
‘Cannabis in Parkinson’s Disease: Growing Like a Weed!’
“Cannabis in Parkinson’s Disease: Growing Like a Weed!” was presented at the University of Colorado School of Medicine’s Neurology Grand Rounds on Jan. 18, 2017.
Could This Study Could Be Disastrous for Marijuana Stocks?
A comprehensive study slams many of the alleged benefits of marijuana and points to serious negative effects. What will the impact of this study be for marijuana stocks?
DEA Issues New Rule to Ban Cannabidiol
On Dec. 14, 2016, the United States Drug Enforcement Administration announced a new rule that makes hemp-based cannabidiol a federally illegal substance. Under the new rules, liquid extracts derived from plants of the cannabis genus that contain one or more cannabinoids are now considered a schedule I substance.
DEA Hurts Growing Industry and Exceeds its Authority Regarding Scheduling Controlled Substances; Enacts Final Rule Seeking to Make Any Extract of the Cannabis Plant a Schedule 1 Drug
DENVER, Dec. 15, 2016 /Weed Wire/ — On December 13, 2016, the DEA issued its Final Rule, “Establishment of New Drug Code for Marihuana Extract,” which serves to potentially devastate developing businesses and consumer, textile and manufacturing industries related to cannabinoids.
Dive into the Science and Medicine of Cannabis
Cannabinoids – what are they? How do they affect the human body? Are they really medicinal? On Nov. 16, 2016, Marijuana Investor Summit is bringing the Science and Medicine of Cannabis to the Palms Casino Resort in Las Vegas, Nevada, to answer these questions and more.
Alaska Welcomes First Marijuana Testing Lab
On Oct. 24, 2016, Alaska’s first marijuana testing lab opened for business. CannTest LLC, in Ship Creek, opened its doors at 10:30 a.m. and was immediately met with 15 samples to test from two marijuana cultivators — Greatland Ganja and Green Rush Gardens LLC.
Structure of Primary Cannabinoid Receptor is Revealed
NEW YORK, Oct. 20, 2016 /Weed Wire/ — New research is providing a more detailed view into the structure of the human cannabinoid (CB1) receptor.
Skinvisible Signs Global Licensing Agreement for Its Cannabis Products
LAS VEGAS, Sept. 15, 2016 /Weed Wire/ — Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI), developers of patented Invisicare® polymer delivery systems, announces it has licensed the exclusive world rights to its topical and transdermal cannabis products formulated with Invisicare to CannaSkin, LLC, a cannabis product licensing company with international contacts in the medical marijuana industry.
Former NFL Player Begins Column For The Cannabist
Medical marijuana advocate and former Baltimore Ravens player Eugene Monroe published his first column for The Cannabist on Aug. 1, 2016. “On a mission to get the NFL to accept cannabinoids as a viable option for pain,” says part of Monroe’s biographical information at the end of the column. The Baltimore Ravens released Monroe in June 2016.
Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets
IRVINE, Calif., July 29, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce they will release an inhalation medication for those suffering asthma/COPD for use in patient nebulizers.
Study: THC May Help Treat Alzheimer’s Disease
While marijuana may be the culprit of some short term memory loss, new research seems to suggest that an active chemical in the substance, THC, may be the key in the prevention and treatment of Alzheimer’s disease.
Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center
LOS ANGELES, June 30, 2016 /Weed Wire/ — Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California.
Ravens’ Eugene Monroe Makes Big Donation to Marijuana research
The Ravens wouldn’t draft a left tackle who they knew was smoking marijuana through a gas mask. But a left tackle who is on their roster for now has made a major contribution to marijuana research.
Enter Cannabis 2.0: LucidMood Launches Online Marketplace
On April 20, 2016, Chooze Corp. launched its first product, LucidMood, a line of vaporizable pucks infused with terpenes, distinctive aromatic compounds, that induce immediate shifts in the individual moods of those who have THC in their systems.
Chooze Corp. develops Mood-enhancing Cannabis products — brands that deliver the mood-enhancing effects of cannabis in the safest, healthiest, most environmentally conscious way possible. Our first product, LucidMood, is a line of terpene-infused vaporizable pucks that produce an immediate shift in the mood of anyone who has THC in their system.
Scientists: Cannabis Can Help Heal Brain Cells Damaged by Alcohol
The vast healing properties of the cannabis plant are becoming more and more widely known. The actual scientific knowledge behind why and how cannabinoids are an invaluable treatment and medication is sadly not widespread.
Evoxe Laboratories creates cannabis vaporizer pens specifically formulated to enhance the natural properties of cannabinoids for a dynamic, consistent, and therapeutic experience.
Paralympic Athlete Suspended After Testing Positive for Cannabinoids
On Tuesday, Nov. 17, 2015, the International Paralympic Committee announced that it has suspended Alexander Zverev, a Russian Paralympic sprinter, for violating a rule of the World Anti-Doping Agency.
DigiPath Labs Successfully Completes Proficiency Testing for Cannabis Potency
LAS VEGAS, Oct. 9, 2015 /PRNewswire/ — DigiPath Labs, a subsidiary of DigiPath, Inc.(OTCBB and OTCQB: DIGP), recently successfully completed voluntary proficiency testing of its ability to detect cannabinoids and terpenoids, accurately identifying potency levels of five cannabinoids and 10 terpenoids in unknown samples.
Scientists Can Now Synthesize THC From Yeast Cells
A recent breakthrough made by researchers from the Technical University of Dortmund in Germany could hold the key to unlocking the secrets of the healing effects of marijuana.
Pet-friendly Cannabis: Do Your Research
Because research is relatively underdeveloped in the segment of cannabis for pet health, there is ample opportunity for companies to find a strong foothold and ultimately stake claim to this market.
Study Shows Link Between Medical Marijuana and Seizure Prevention
A recent study seems to back up claims made by parents and patients that medical marijuana could help intractable seizures.
Evoxe Labs Announces Medicinal Cannabis Product Launch
LOS ANGELES, Aug. 24, 2015 /PRNewswire/ — Evoxe Laboratories, the new and pioneering developer of medicinal cannabis consumption technologies, today announces their debut product offerings in California, as well as partnerships with Sacramento’s TBD Music Festival and Irvine’s Safe In Sound Festival this September.
Under the Hood at Potbotics
No matter how much “counterculture” stereotypes continue to permeate parts of the industry if not the overall debate, the bottom line in the marijuana business is getting increasingly technical, medical and bottom line.
Zynerba IPO a Big $275 Million Entry for Cannabinoids
It has been a bit of a dry spell for decent IPOs in the cannabis space. But the rains have come down with the initial public offering of Devon, Pennsylvania-based Zynerba Pharmaceuticals (NASDAQ: ZYNE).
Study: Medical Marijuana May Help Heal Broken Bones
When people say “medical marijuana,” they often think of cancer patients, people suffering from PTSD, or persons struggling with chronic pain. There is a huge laundry list of ailments that medical marijuana can purportedly treat, and the newest addition to that list is broken bones.
MyDx Looks to Crack Open the Green Leaf
MyDx’s hardware/software ecosystem has a very easy value proposition to dish out: simple, instant testing of solids, liquids and gases to measure their positive attributes, and whether there’s any pesticides or other no-gooders in your food, water and air.
CannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYC
NEW YORK, N.Y., June 17, 2015 /PR Newswire/ — CannaPharmaRx (OTCQB:CPMD), a leader in the research, development, and commercialization of cannabinoid-based drug products, is pleased to announce that it will be exhibiting at the 2nd Annual Cannabis World Congress & Business Expo. The conference will be held at the Jacob Javits Center in New York, NY from Wednesday, June 17 through Friday, June 19. CannaPharmaRx will exhibit in booth # 316.
Science Crowdfunding Startup Launches Cannabis Cancer Cure Research Campaign
Science crowdfunding startup Walacea is helping Madrid’s MedicalCannabis Bike Tour to raise the final €85,000 it needs to conduct an independent clinical trial into the effect of cannabinoids on brain tumours.
A Biotech Future for Marijuana?
It is often thought that the economic future for recreational marijuana is relatively limited. The people who use it for fun will eventually move from the black market to the legal market.
OXIS Reverse Stock Split: A Case Study
Oxis Biotech, a subsidiary of Oxis International (OTCQB: OXIS), recently filed a notification to shareholders and the SEC that the company would be entering into a reverse split of not less than 1-50 shares and not more than 1-250 shares.
Therapeutic Potential for Infused Topicals
Two Colorado companies, Apothecanna, and Mary Jane’s Medicinals are at the forefront of the topicals movement.
How Cannabis-based Drugmaker GW Finally Cracked America
When a pair of British doctors set out to make medicines from the cannabis plant 16 years ago, they knew it would take some time to crack the world’s biggest pharmaceuticals market.